$9.15
+0.230 (+2.58%)
At Close: Jun 23, 2026
Phreesia Named as One of Modern Healthcare's “Best Places to Work in Healthcare” for the Eighth Time
04:30pm, Tuesday, 21'st May 2024
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by Modern Healthcare as one of the 2024 Best Places to Work in Healthcare.
National Bank of Canada FI Invests $46,000 in Sphere Entertainment Co. (NYSE:SPHR)
05:06am, Monday, 20'th May 2024
National Bank of Canada FI bought a new position in shares of Sphere Entertainment Co. (NYSE:SPHR – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securit
Phreesia's Alicia Cowley and Natasha Vega Named to MM+M's ‘Women to Watch' for 2024
06:46am, Wednesday, 01'st May 2024
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Director of Clinical Content Alicia Cowley and Senior Client Experience Manager Natasha Vega named to MM+M's Women to Watch class of 20
Phreesia Sets Release Date for Fiscal First Quarter 2025 Results
06:48am, Monday, 29'th Apr 2024
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia today announced that it will release its fiscal first quarter 2025 financial results after the close of market trading on May 30, 2024.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 09'th Apr 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Phreesia Continues To Stay Positive On The Business Growth
12:18am, Wednesday, 03'rd Apr 2024
Phreesia is expected to continue growing revenue at a rate of 20%+ and see an increase in adjusted EBITDA margin as the business scales. PHR has shown strong customer additions, driving revenue growth
Phreesia Announces Jack Callahan as New Chief Technology Officer
06:48am, Tuesday, 19'th Mar 2024
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company's new Chief Technology Officer.
Phreesia, Inc. (PHR) Q4 2024 Earnings Call Transcript
09:01pm, Thursday, 14'th Mar 2024
Phreesia, Inc. (PHR) Q4 2024 Earnings Call Transcript
Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
07:00pm, Thursday, 14'th Mar 2024
Although the revenue and EPS for Phreesia (PHR) give a sense of how its business performed in the quarter ended January 2024, it might be worth considering how some key metrics compare with Wall Stree
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
06:25pm, Thursday, 14'th Mar 2024
Phreesia (PHR) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.72 per share a year ago.
Phreesia Announces Fourth Quarter Fiscal 2024 Results
04:03pm, Thursday, 14'th Mar 2024
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
Will Phreesia (PHR) Report Negative Earnings Next Week? What You Should Know
11:01am, Thursday, 07'th Mar 2024
Phreesia (PHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Phreesia's Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
04:05pm, Tuesday, 27'th Feb 2024
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
04:05pm, Monday, 05'th Feb 2024
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal fourth quarter 2024 financial results after the close of market trading on Thursday, March 14, 2024.
Bull Of The Day: Phreesia (PHR)
07:56am, Monday, 05'th Feb 2024
Phreesia (PHR) is a Zacks Rank #1 (Strong Buy) that has a F for Value and B for Growth. This is medical information systems company is flying under the radar of most investors as it is a small cap a
Sign In
Buy PHR